Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2016-12-05 16:34:15
Reporting Period:
Filing Date:
Accepted Time:
2016-12-05 16:34:15
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
875045 Biogen Inc. BIIB Biological Products, (No Disgnostic Substances) (2836) 330112644
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1619963 Adriana Karaboutis Biogen Inc.
225 Binney Street
Cambridge MA 02142
Evp, Tech, Bus. Sol & Corp Aff No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-12-01 171 $295.78 7,408 No 4 F Direct
Common Stock Disposition 2016-12-01 48 $296.53 7,360 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 S Direct
  1. Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.